Last reviewed · How we verify
NCT04671979
Serum Lactate in Acute Mesenteric Ischemia
trial testing Lactate Dehydrogenase in Mesenteric Ischemia in 74 participants. Completed in 30 June 2020.
30 June 2020
Quick facts
| Lead sponsor | Universidad del Rosario |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 74 |
| Start date | 2 May 2017 |
| Primary completion | 30 June 2020 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across Colombia |
Drugs / interventions tested
- Lactate Dehydrogenase
Conditions studied
- Mesenteric Ischemia — all drugs for Mesenteric Ischemia →
Sponsor
Universidad del Rosario
Who can join
18 and older, any sex, with Mesenteric Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Acute mesenteric ischemia is a vascular emergency with high mortality because of ambiguous symptomatology and a lack of early diagnostic markers. Lactate dehydrogenase has been described as a mortality biomarker and bowel necrosis length too. Nevertheless, the association between them has been mildly studied. Our objective was to evaluate the association between serum lactate admission levels, bowel necrosis extension, and mortality. Additionally, we performed a mortality characterization. Materials and Methods: A retrospective cross-sectional study was designed. We reviewed patients' clinical records with acute mesenteric ischemia that attended a hospital between 2012 and 2018. We compared serum lactate admission levels with bowel necrosis length and mortality. A receiver operating characteristic curve was performed on the last association. As post hoc analysis, a classification and regression tree on mortality was fitted.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04671979
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mesenteric Ischemia
Currently open trials in the same condition.
- NCT05468580 — Coeliac Artery Release or Sham Operation · NA · recruiting
- NCT04746534 — Cohort SURVI : Intestinal Ischemia and Vascular Diseases · recruiting
Other Universidad del Rosario trials
Trials by the same sponsor.
- NCT05207527 — Intradialisis Physical Exercise in Quality of Life and Health · NA · not yet recruiting
- NCT05057741 — Surgical Prehabilitation in Abdominal Surgery · NA · completed
- NCT04332835 — Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study · Phase 2, PHASE3 · completed
- NCT04332380 — Convalescent Plasma for Patients With COVID-19: A Pilot Study · Phase 2 · completed
- NCT03593850 — Music for Pain in Primary Dysmenorrhea · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04671979 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad del Rosario
- Last refreshed: 17 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04671979.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing